LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3 - Amendment to purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 04 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long |
Short |
||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
1,864,894 |
1.45% |
231,530 |
0.18% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
72,359 |
0.06% |
94,581 |
0.07% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
purchase/sell: | 6,100 |
0.00% |
6,100 |
0.00% |
|
|
|
|
|
||
TOTAL: |
|
|
|
|
|
1,943,353 |
1.51% |
332,211 |
0.26% |
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities |
Price per unit |
Purchase | 1 |
257.6900 USD |
Purchase | 2 |
258.0400 USD |
Purchase | 3 |
259.8200 USD |
Purchase | 5 |
259.6180 USD |
Purchase | 5 |
257.5440 USD |
Purchase | 13 |
257.9469 USD |
Purchase | 14 |
256.3600 USD |
Purchase | 15 |
259.5346 USD |
Purchase | 35 |
256.4200 USD |
Purchase | 68 |
258.4900 USD |
Purchase | 83 |
256.6534 USD |
Purchase | 102 |
260.4370 USD |
Purchase | 171 |
258.7400 USD |
Purchase | 190 |
260.2721 USD |
Purchase | 200 |
258.6375 USD |
Purchase | 300 |
258.6300 USD |
Purchase | 353 |
260.4420 USD |
Purchase | 410 |
257.9000 USD |
Purchase | 476 |
260.3720 USD |
Purchase | 507 |
257.8273 USD |
Purchase | 514 |
258.3779 USD |
Purchase | 910 |
259.6878 USD |
Purchase | 953 |
258.3477 USD |
Purchase | 983 |
257.7908 USD |
Purchase | 1,102 |
257.2963 USD |
Purchase | 1,130 |
258.0164 USD |
Purchase | 2,176 |
258.6069 USD |
Purchase | 2,684 |
259.7866 USD |
Purchase | 3,753 |
260.5128 USD |
Purchase | 4,429 |
257.8573 USD |
Purchase | 5,334 |
258.3442 USD |
Purchase | 6,539 |
259.5923 USD |
Purchase | 7,657 |
258.4409 USD |
Purchase | 22,055 |
256.6217 USD |
Purchase | 22,526 |
258.0725 USD |
Purchase | 31,259 |
259.7300 USD |
Sale | 1 |
256.4700 USD |
Sale | 1 |
258.5800 USD |
Sale | 3 |
257.6500 USD |
Sale | 4 |
256.8875 USD |
Sale | 70 |
257.5800 USD |
Sale | 90 |
257.8547 USD |
Sale | 100 |
256.6000 USD |
Sale | 100 |
257.9700 USD |
Sale | 100 |
256.9600 USD |
Sale | 103 |
257.9835 USD |
Sale | 104 |
258.3220 USD |
Sale | 136 |
258.7400 USD |
Sale | 200 |
258.1350 USD |
Sale | 200 |
256.6500 USD |
Sale | 300 |
256.7500 USD |
Sale | 400 |
256.7375 USD |
Sale | 406 |
256.8012 USD |
Sale | 567 |
258.5375 USD |
Sale | 791 |
259.4937 USD |
Sale | 910 |
259.6878 USD |
Sale | 940 |
256.7765 USD |
Sale | 1,047 |
257.5087 USD |
Sale | 1,270 |
259.7300 USD |
Sale | 1,499 |
257.8919 USD |
Sale | 1,989 |
259.6121 USD |
Sale | 1,990 |
258.3417 USD |
Sale | 2,216 |
256.7358 USD |
Sale | 2,700 |
258.4094 USD |
Sale | 3,704 |
257.5944 USD |
Sale | 4,046 |
258.3765 USD |
Sale | 5,870 |
256.9059 USD |
Sale | 7,504 |
258.4356 USD |
Sale | 10,038 |
260.5217 USD |
Sale | 11,623 |
256.4300 USD |
Sale | 11,931 |
259.7299 USD |
Sale | 19,087 |
259.6931 USD |
Sale | 25,350 |
257.9964 USD |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction |
Number of relevant securities |
Price per |
|
|
unit |
|
SWAP | Long |
71,000 |
259.7300 USD |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 8 Jun 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or |
Number of |
Exercise |
Type |
Expiry |
purchased |
relevant securities |
price |
|
date |
|
|
to which the option |
|
|
|
|
|
or derivative |
|
|
|
|
|
relates |
|
|
|
|
Put Options | Purchased |
-100 |
220.0000 |
American |
Jul 16, 2021 |
Call Options | Purchased |
100 |
240.0000 |
American |
Jul 16, 2021 |
Call Options | Purchased |
6,000 |
220.0000 |
American |
Jul 16, 2021 |
Put Options | Purchased |
-6,000 |
200.0000 |
American |
Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.